ALKS FY 2018 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.1B+21.1% YoY

Gross Profit

$918M83.9% margin

Operating Income

-$99M-9.1% margin

Net Income

-$139M-12.7% margin

EPS (Diluted)

$-0.90

Cash Flow

Operating Cash Flow

$99M

Free Cash Flow

$30M

Stock-Based Comp.

$105M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$654M

Stockholders' Equity

$1.2B

Cash & Equivalents

$267M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$903M	+21.1%
Gross Profit	$918M	$749M	+22.6%
Operating Income	-$99M	-$148M	+33.0%
Net Income	-$139M	-$158M	+11.8%